Evaluation of the Safety and Efficacy of Standard Intravenous Immunoglobulins in Pregnant Women With Primary Cytomegalovirus Infection

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
Because the potential benefit of standard intravenous immunoglobulins (IVIG) - obtained from unselected donor pools including a varying proportion of donors previously exposed to CMV - has not yet been explored in pregnant women, the investigators performed a longitudinal prospective study on the possible efficacy of IVIG for prevention or therapy of fetal CMV infection.
Epistemonikos ID: 0061b3d26b2b4f198cd6e4e4eefb1e76f2f95e97
First added on: May 11, 2024